SYNACT PHARMA ApS
34459975ActiveClinical-stage biotech company developing innovative therapies to resolve inflammation.
Oversikt
- 6
- Ansatte
- Ukjent
- Omsetning
- 2012
- Grunnlagt
Nøkkelbeslutningstakere
Ann Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
+14 flere kontakter i Funnelfeedr
Beskrivelse
SynAct Pharma is a clinical-stage biotechnology company based in Sweden and Denmark that focuses on developing innovative therapies to resolve inflammation rather than simply inhibiting it. Their lead drug candidate, Resomelagon (AP1189), is a once-daily oral therapy designed to selectively activate...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- APS
- MVA-nummer
- DK34459975
Beslutningstakere
18 kontakter i FunnelfeedrAnn Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
Mauro Perretti
Advisory Board Member
Malin Wikstrand
Interim Chief Financial Officer
Jeppe Ragnar Andersen
Board Member
Thomas Boesen
Chief Operating Officer
James Knight
Advisory Board Member
Vibeke Strand
Advisory Board Member
Thomas Jonassen
Chief Scientific Officer
Sten Scheibye
Board Member
Mads Bjerregaard
Chief Business Officer
Kirsten Harting
Chief Medical Officer
Sten Sörensen
Board Member
Anders Kronborg
Chairman of the Board
Torbjørn Bjerke
Chief Executive Officer
Mauro Teixeira
Advisory Board Member
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrEvaxion A/S
44 ansatteAI-driven TechBio company developing personalized vaccines for cancer and infections.
Novakand Pharma AB
5–9 ansatteDeveloping novel small-molecule drugs for inflammation and cancer.
VIROGATES A/S
8 ansatteViroGates provides innovative suPAR-based diagnostic solutions for clinical risk stratification.
BIOTAGE SWEDEN AB
Global partner providing separation and purification workflow solutions for life sciences.
Inicure AB
0 ansatteDeveloping novel small molecules to combat resistant bacterial infections effectively.
Utforsk mer
Spørsmål om SYNACT PHARMA ApS
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo